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Radial versus right internal thoracic artery as a second
arterial conduit for coronary surgery: Early and midterm
outcomes
Bruce W. Lytle, MD
See related article on page 39. The left internal thoracic artery (LITA) to left anterior descendingcoronary artery (LAD) graft is now a fundamental part of operationsfor coronary revascularization. There is a mountain of observationalevidence that this strategy produces short- and long-term outcomesthat are superior to a vein graft–only strategy. The LITA-LAD grafthas higher early and later patency rates than vein grafts and de-
creases the risk of early and late death. A lesser, but increasingly substantial, body
of evidence from multiple institutions appears to show that bilateral ITA grafting
improves outcomes relative to a single ITA graft strategy. Reactivation of the use of
the radial artery (RA) as a bypass graft has provided the option of substituting the
RA for the right internal thoracic artery (RITA) as a second arterial bypass graft.
There are many potential advantages of using the RA instead of the RITA graft.
The RA is larger and easier to work with than the RITA, its preparation is
straightforward, can be accomplished during the LITA dissection, and using the RA
instead of the RITA avoids any increase in sternal wound complications associated
with bilateral ITA grafting. However, it is not known whether substituting the RA
for the RITA as a second arterial graft provides similar revascularization outcomes
to a bilateral ITA strategy. Is the RA as good a coronary bypass graft as the RITA?
The article by Caputo and associates1 in this issue of the Journal attempts to shed
light on this question.
In their retrospective observational study, short-term (mean follow-up 18
months) clinical outcomes are compared for patients receiving LITA-RA grafts with
those for patients receiving LITA-RITA grafts. The conclusion of the authors was
that, in their hands, the RA graft was not only as good a graft as the RITA but that
it produced better short-term outcomes. Patients with RA grafts had fewer periop-
erative events (in particular, fewer blood transfusions and episodes of atrial fibril-
lation) and a lower risk of early out-of-hospital events, primarily because of a lower
rate of recurrent angina. This is interesting information and reflects the experience
of that center. However, this study does not yet provide the kind of information that
would allow us to reach the general conclusion that the RA is a superior bypass graft
to the RITA.
According to the authors, only 15% of their patients undergoing revascularization
during the time period of the study received two arterial bypass grafts of any kind,
indicating that this center was not heavily committed to the use of arterial grafts at
that time. Some of the adverse outcomes of the patients who received RITA grafts,
in particular myocardial infarction and return of angina, may have been technically
related rather than being related to the intrinsic ability of the graft to stay patent and
relieve ischemia. These are short-term ischemic outcomes. In our study that com-
pared bilateral versus single ITA grafting, in essence testing the RITA versus vein
grafts, differences in clinical outcomes did not become apparent until about 6 years
after the operation, when vein graft failure due to intimal fibroplasia and graft
atherosclerosis begins to appear. The outcomes reported by Caputo and associates
were essentially perioperative. Most surgeons would agree that the use of the RITA
is technically more demanding than is the use of the RA, but as experience with
arterial grafting increases, the technical complications of RITA grafting may di-
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minish. Also, the authors point out that the RITA was
commonly used as an in situ graft to the right coronary
artery, a strategy subject to a higher risk of graft failure than
other graft–coronary artery combinations. Although they
note that this is a problem with their analysis and state that
statistical adjustments were made, the number of patients
and adverse events were relatively small and it is unclear
what those adjustments could be.
Two questions still remain. Does the incremental tech-
nical difficulty of RITA grafting produce a fixed rate of
graft attrition that will be difficult to overcome? And, does
the RITA possess a better intrinsic tendency to stay patent
over the long term compared with the RA? Although we
have an enormous amount of information available regard-
ing the patency of the LITA-LAD graft, less data exists
involving the use of either the RITA or LITA to other
vessels, and those data that we do have indicate inferior
patency rates to the LITA-LAD gold standard. We do know
that RITA grafts are capable of remaining patent for 20
years without becoming atherosclerotic. Studies of RA
grafts demonstrate perfect patency rates of 80% to 87% at 5
years, and anecdotally we and others have noted radial
artery graft patency at 8 to 10 years after operation. Both
RITA and RA grafts have diminished patency rates when
grafted to coronary vessels that have mild or moderate
obstructions.
My opinion regarding the answers to the two questions is
that the technical costs of RITA grafting do diminish with
experience and that given a “perfect” situation (a graft to a
tightly stenotic branch of the left coronary system) the
RITA will have a better long-term patency rate than an RA
graft. That opinion is based on a number of somewhat
anecdotal observations. (1) There is a high rate of success
with the RITA when used in this “perfect” situation. (2) We
know that RITA grafts can continue to be patent for at least
20 years after operation. (3) We know that when the LITA
is used as a graft to the LAD, it is not only possible but
probable that it will function well more than 20 years after
the operation; it is hard to understand what fundamental
difference there would be between the LITA and the RITA
in this regard. (4) My colleagues and I have noted anecdotal
occlusions of RA grafts placed in “perfect” situations that
are hard to understand. There are certainly many RA grafts
that have functioned well in those “perfect” situations, but
even anecdotal occlusions are somewhat disturbing. In my
judgment, the RA graft is less predictable than the RITA
graft in regard to patency. I am painfully aware that these
opinions are not conclusions based entirely on statistically
significant randomized or even prospective data, but they
are my opinions at this time.
The RA is clearly a useful graft and many patients will
benefit from both RA and RITA grafts. The advantages and
disadvantages of both will depend on patient-related, con-
duit-related, coronary artery–related, and surgeon-related
variables. Currently I personally use the RITA in preference
to the RA for most patients. The study of Caputo and
associates provides important information and is a good
point of reference from which to start, but this is an impor-
tant question necessitating much more data.
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